Found 11 matching trials
A Efficacy and Safety Study of Ranibizumab 10mg/ml Injection (Incepta) in Patients With Diabetic Macular Edema PHASE3 Macular edema in diabetes, defined as retinal thickening within two disc di...
Show More Location
Bangladesh Eye Hospital & Institute
Learn More & Join Trial
Safety Study of PF582 Versus Lucentis in Patients With Age Related Macular Degeneration PHASE1 The aim of this study is to test if PF582 (ranibizumab) is safe and similar...
Show More Learn More & Join Trial
A Study To Evaluate CKD-701 and Lucentis® in Patients With Neovascular(Wet) Age Related Macular Degeneration PHASE3 This is a multicenter, randomized, double-blind, active-controlled, paralle...
Show More Location
Seoul National University Hospital
Learn More & Join Trial
A Study to Compare SB11 (Proposed Ranibizumab Biosimilar) to Lucentis in Subjects With Neovascular Age-related Macular Degeneration (AMD) PHASE3 This is a randomised, double-masked, parallel group, multicentre study to e...
Show More Location
Retina consultants San Diego
Learn More & Join Trial
Efficacy and Safety of the Biosimilar Ranibizumab FYB201 in Comparison to Lucentis in Patients With Neovascular Age-related Macular Degeneration PHASE3 The purpose of this study is to determine the efficacy and safety of the bi...
Show More Learn More & Join Trial
Effectiveness of Biosimilar Ranibizumab in the Management of Diabetic Macular Edema N/A Diabetic macular edema (DME) is a leading cause of vision loss in patients ...
Show More Learn More & Join Trial
Study to Compare Efficacy, Safety, and Immunogenicity of LUBT010 (Proposed Ranibizumab Biosimilar) and Lucentis® in Patients With Neovascular AMD PHASE3 This study is designed to compare the efficacy, safety and immunogenicity o...
Show More Location
Retina-Vitreous Associates Medical Group
Learn More & Join Trial
Biomarkers in Diabetic Retinopathy Treated With Faricimab vs Biosimilar Ranibizumab NA The goal of this clinical trial is to see if treatment with faricimab or bi...
Show More Location
University Hospital Osijek
Learn More & Join Trial
Anti-vascular Endothelial Growth Factor (Anti-VEGF) Monotherapy vs Anti-VEGF Followed by Subthreshold Micropulse Laser for Treating Severe Diabetic Macular Oedema When the Central Retina Goes <400 Microns PHASE3 The macula is the centre of the retina; it gives central sight, colour and ...
Show More Location
The Royal Hospitals Belfast
Learn More & Join Trial
Comparing the Efficacy and Safety of Biosimilar Candidate Xlucane Versus Lucentis® in Patients With nAMD PHASE3 The objectives of the study are to demonstrate the equivalence of Xlucane t...
Show More Location
Retinal Research Institute, LLC
Learn More & Join Trial